Iqvia Germany company information, Employees & Contact Information

eTMF IQVIA

IQVIA ONEKEY SOLUTIONS IQVIA

FlexView IQVIA

Data-as-a-Service (DaaS) IQVIA

Global Trends in R&D 2025 IQVIA

Pricing and Market Access IQVIA

OneKey HCP Reference Data IQVIA

Brand Strategy and Management IQVIA

The Future of Pharmacovigilance: Integrating AI with Drug Safety Systems IQVIA

The Convergence of Medical Devices and Digital Health: What’s Next? IQVIA

A Brave New World: Six Key Healthcare Industry Trends to Monitor in 2025 for Emerging Biopharma IQVIA

THE BREADTH OF CHEMICAL INTELLIGENCE DATA IQVIA

Forecasting & Franchise Strategy IQVIA

Site and Investigators IQVIA

Navigating an Uncertain Future: Strategic Insights from 2024 Global OTC Performance IQVIA

Primary Intelligence IQVIA

Inside Agentic AI: Reshaping Decisions and Orchestration in Life Sciences IQVIA

Introducing Rosters & Alignments IQVIA

How Early-Stage Planning Strategies Are Optimizing Drug Development IQVIA

Digital Solutions for Obesity: Revolutionising Care and Management IQVIA

Commercial Engagement Services IQVIA

Aim higher and transform trials with Direct-to-Patient Recruitment. IQVIA

INNsight Newsletter IQVIA

Today’s Investigator Databank and DQS: Welcoming the Next Generation of Consortium Members IQVIA

Digital Health Trends 2024 IQVIA

Three ways to simplify site processes: Insights from industry leaders at IQVIA Innovation Day, SCOPE Summit 2025 IQVIA

How AI is shaking up compliance in the life sciences industry IQVIA

Best use cases for scaling agentic AI in commercial life sciences IQVIA

Transforming Clinical Trial Design Development with Digital Innovation IQVIA

Introducing IQVIA’s Data as a Service (DaaS): A New Era in Data Delivery IQVIA

Biopharma M&A: Outlook for 2025 IQVIA

Navigating international data collection for patient organizations IQVIA

Forecast Horizon IQVIA

Rethinking the tuberculosis response in times of change: The current state of affairs and perspectives on the future IQVIA

IQVIA Alerts reduced Sales Reps' lead to engagement time from 5 weeks to 48 hours with daily triggers IQVIA

How the Lancet Commission and FDA are moving the goal posts in obesity IQVIA

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 Business Wire

Optimizing Remote Monitoring with FSP IQVIA

3 Guiding Principles for Defensible & Impactful AI in Healthcare IQVIA

Measure Pharma Sales Effectiveness: Understanding the BrandImpact™ Score IQVIA

Overcoming Regulatory Challenges in APAC Cell and Gene Therapy Development IQVIA

Incentive 360 IQVIA

Testing of biomarkers in Oncology IQVIA

Leveraging Synthetic Control Arms in Clinical Trials and RWE Studies IQVIA

Tuning in: Understanding Healthcare Professionals’ Changing Channel Preferences to Build Better Engagement IQVIA

Why Now is the Time for Patient Data Initiatives IQVIA

2025 Indicators of Progress for the Life Sciences Sector IQVIA

Doctors and Obesity: Are healthcare professionals ready for the new anti-obesity medications? IQVIA

Chronic Obstructive Pulmonary Disease (COPD) in Malaysia IQVIA

How AI is Revolutionizing Clinical Trial Payments and Operations: Insights from IQVIA IQVIA

AI Trends in Pharma: Enhancing Drug Safety and Regulatory Compliance for 2025 IQVIA

Top Five Insights from the Informa Patient Support Services Congress: Creating Change IQVIA

The Changing Oncology Landscape: Considerations for Patient Organizations IQVIA

In-depth patient insights in obesity highlight the need for a holistic, individualised approach to therapy IQVIA

Beyond Healthcare IQVIA

Natural Language Processing IQVIA

EMEA Data Centralization: A Strategic Approach for Life Sciences IQVIA

Navigating Antimicrobial Resistance IQVIA

Simplifying Digital HCP Engagement: The Seamless Solution for Authentication, Consent and Data Collection IQVIA

The Crucial Role of Real-Time Data Use in Pharma Marketing IQVIA

Clinical Data Analytics Solutions IQVIA

list, ranked No. 1 in its sector for fourth consecutive year Business Wire

Strengthening the malaria response: Where to go next? IQVIA

Revolutionizing Life Sciences: The Strategic Edge of Generative AI IQVIA

RNA Therapeutics IQVIA

2024: The obesity market’s inflection point? IQVIA

Safety & Regulatory Compliance Solutions IQVIA

IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing IQVIA

Global Medical Information Services Enhanced by AI/NLP IQVIA

Natural Language Processing (NLP) Insights Hub IQVIA

Africa’s next chapter: a continent of opportunity IQVIA

Tackling tolerability: The next challenge facing obesity therapies IQVIA

The Impact of Biosimilar Competition in Europe 2021 IQVIA

Harmonized Quality IQVIA

The future of AI in healthcare IQVIA

Life Sciences Regulatory Compliance Solutions IQVIA

Data Modernization: Advancing Federal Healthcare Data IQVIA

Drug Safety and Pharmacovigilance IQVIA

Real world evidence. Real Confidence. Real Results. IQVIA

RIM Smart - Regulatory Information Management System IQVIA

EMEA Thought Leadership IQVIA

Defining Essential Innovative Medicines and Measuring their Use in Europe IQVIA

The Cost of the 340B Program Part 1: Self-Insured Employers IQVIA

Real World & Healthcare Data IQVIA

Patient Support Program IQVIA

APAC perspective on Fostering Success in CNS Innovation IQVIA

Advanced Analytics Solution for the Longitudinal Access and Adjudication Data Set IQVIA

Patient Engagement Suite IQVIA

Interactive Order Management IQVIA

How will the EU Pharmaceutical revision impact you? IQVIA

Unlocking clinical and commercial success: How PAGs power rare disease research IQVIA

How rare diseases add up, making them a high public health priority IQVIA

Market Access Insights IQVIA

Health Data Transformation IQVIA

Partnerships in Cell and Gene Therapy Clinical Trials IQVIA

The Growing Value of Digital Health IQVIA

Clinical Data Analytics Solutions IQVIA

Medicine Use and Spending in the U.S. IQVIA

Succeeding with Innovation: State of Radioligand Therapy Readiness in Europe IQVIA

IQVIA United Kingdom IQVIA